Recent Updates
Recently added Catalysts
EBS Positive Sentiment

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Key Takeaway: Emergent BioSolutions Inc. will participate in several upcoming investor conferences, including the Goldman Sachs 11th Annual Leveraged Finance and Credit Conference and the Jefferies Global Healthcare Conference. These events will provide opportunities for the company's senior management to engage with investors and discuss their mission to protect public health. The presentations will be available via webcast.
Price reaction · baseline $8.06 (2026-05-19 close) · hit after-hours · clean, no other EBS news in the window
day 0 close · peak
+1.1%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions is actively engaging with investors.
  • Participation in multiple prestigious healthcare conferences.
  • Opportunity for one-on-one meetings with senior management.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+70%
120-day peak, hindsight
Typical move
8%
average across 2 past catalysts
Lead asset
FLU-IGIV
Phase 2 · Influenza A H3N2

Full Press Release Details

GAITHERSBURG, Md., May 20, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:
• Goldman Sachs 11th Annual Leveraged Finance and Credit Conference, May 27-29
• Benchmark 6th Annual Healthcare House Call Virtual Investor Conference, May 28
• Jefferies Global Healthcare Conference, June 2-4June 3: presentation and webcast, 1:20-1:50 p.m. eastern time, registerhere.
• June 3: presentation and webcast, 1:20-1:50 p.m. eastern time, registerhere.
• Goldman Sachs 47th Annual Global Healthcare Conference, June 8-10June 8: presentation and webcast, 2:00-3:00 p.m. eastern time, registerhere.
• June 8: presentation and webcast, 2:00-3:00 p.m. eastern time, registerhere.
Please contact a conference representative to request one-on-one meetings.
About Emergent BioSolutionsAt Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit ourwebsiteand follow us onLinkedIn,X,Instagram,Apple PodcastsandSpotify.

Investor Contact:Richard S. LindahlExecutive Vice President, CFOlindahlr@ebsi.com

Media Contact:Assal HellmerVice President, Communicationsmediarelations@ebsi.com

Frequently Asked Questions

What conferences will Emergent BioSolutions attend?

Emergent BioSolutions will participate in several conferences, including the Goldman Sachs 11th Annual Leveraged Finance and Credit Conference and the Jefferies Global Healthcare Conference.

When is the Jefferies Global Healthcare Conference?

The Jefferies Global Healthcare Conference is scheduled for June 2-4, 2026.

How can investors meet with Emergent's management?

Investors can request one-on-one meetings with Emergent's senior management by contacting a conference representative.

What is the mission of Emergent BioSolutions?

Emergent BioSolutions aims to protect and save lives by delivering solutions for various health threats.

Last updated: May 20, 2026